We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • Sinclair slims down

    27 November 2015

    After a year's worth of deal, Sinclair IS Pharma will focus purely on aesthetic dermatology.
  • Circassia takes on GSK Tip Update

    25 November 2015

    Circassia has dipped its toe into the generics market as it takes on GSK with a new asthma drug.
  • Breath of fresh air at Vectura

    17 November 2015

    The new chief executive at Vectura has yet to lay out a vision for the drug development group
  • Varithena concern hits BTG Tip Update

    10 November 2015

    In light of a new regulatory issue, we're changing our view on pharma group BTG.
  • Shire signs Dyax deal

    05 November 2015

    It's still keen on a mammoth merger with US group Baxalta, but Shire will buy Dyax for $5.9bn first

Register today and get...

Register today and get...
Please note terms & conditions apply